Rising Obesity Among Indian Women Threatens Fertility: Dr. S. Vyjayanthi Weighs In

Rising Obesity Among Indian Women Threatens Fertility: Dr. S. Vyjayanthi Weighs In

Sep 25, 2025

Hyderabad (Telangana) [India], September 25: Nearly 50% of Indian women aged between 35 and 49 years are now classified as overweight or obese, according to a recent study reported by The Times of India. The findings raise critical questions about women’s reproductive health

Read More
Egg Freezing Gains Popularity in India: Dr. S. Vyjayanthi on the Future of Fertility Preservation

Egg Freezing Gains Popularity in India: Dr. S. Vyjayanthi on the Future of Fertility Preservation

Sep 25, 2025

Hyderabad (Telangana) [India], September 25:  Fertility preservation is no longer a subject confined to medical textbooks and oncology wards—it is now part of mainstream conversations among India’s urban, career-driven women. One procedure leading this change is egg freezing, and guiding this shift with

Read More
Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences

Sep 25, 2025

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the

Read More
India Gets Its First-Ever, Comprehensive, Most Impactful Breast Cancer Program

India Gets Its First-Ever, Comprehensive, Most Impactful Breast Cancer Program

Sep 25, 2025

New Delhi [India], September 25: With breast cancer on the rise and 1 in 8 Indian women at risk, a landmark initiative blends knowledge, self-advocacy, and risk assessment to transform how India faces its most common women’s cancer. After winning international recognition for

Read More
Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India

Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India

Sep 25, 2025

Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with Enzene Biosciences Limited, this breakthrough aims to

Read More
Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care

Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care

Sep 25, 2025

Hyderabad (Telangana) [India], September 25: Reinforcing the Government of India’s mission to provide equitable healthcare, Hetero Healthcare Limited, in partnership with Enzene Biosciences, has launched Perzea, its most affordable biosimilar Pertuzumab for HER2-positive breast cancer. This initiative underlines the critical need for advanced cancer treatment accessibility in the

Read More
Mauritius to Host 2nd International Musculoskeletal Summit (IMS 2.0) 2025

Mauritius to Host 2nd International Musculoskeletal Summit (IMS 2.0) 2025

Sep 25, 2025

New Delhi [India], September 25: Mauritius is set to become a global hub for musculoskeletal medicine and sports injury management as it hosts the 2nd International Musculoskeletal Summit (IMS 2.0) from September 26–28, 2025, at Hotel Hennessy Park, Ebene. Organized by the Jaipur

Read More